Establishing a center of excellence for hereditary diffuse gastric cancer syndrome

J Surg Oncol. 2019 May;119(6):673-674. doi: 10.1002/jso.25363. Epub 2019 Jan 7.

Justin Drake¹, Karen Chelcun Schreiber², Rachael Lopez^{1

3}, Grace-Ann Fasaye⁴, Maureen Connolly^{1

3}, Martha Quezado^{3

5}, Theo Heller^{3

6}, Jonathan M Hernandez^{1

3}, Jeremy L Davis^{1

3}

¹ Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² HDGC Patient Advocate, HereditaryDiffuseGastricCancer.org, Madison, Wisconsin.
³ NIH Foregut Team, National Institutes of Health, Bethesda, Maryland.
⁴ Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁵ Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
⁶ Translational Hepatology Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

No abstract available

Keywords: CDH1; hereditary diffuse gastric cancer; total gastrectomy.

Publication types